HLA class II molecules and AChR subunit immunity determine ocular myasthenia gravis susceptibility in HLA transgenic mice

被引：0
|
作者：
Christadoss, P
Bednov, A
Saini, SS
Tuzun, E
Yang, H
机构：
来源：
NEUROLOGY | 2006年 / 66卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A256 / A256
页数：1
相关论文
共 50 条
  • [21] COMBINATIONS OF HLA-DPB1 AND HLA-DQB1 ALLELES DETERMINE SUSCEPTIBILITY TO EARLY-ONSET MYASTHENIA-GRAVIS IN JAPAN
    HORIKI, T
    INOKO, H
    MORIUCHI, J
    ICHIKAWA, Y
    ARIMORI, S
    AUTOIMMUNITY, 1994, 19 (01) : 49 - 54
  • [22] THE USE OF THE POLYMERASE CHAIN-REACTION TO ANALYZE HLA CLASS-II SEQUENCE POLYMORPHISM AND GENETIC SUSCEPTIBILITY TO MYASTHENIA-GRAVIS
    BEGOVICH, AB
    OKSENBERG, JR
    GRIFFITH, RL
    STEINMAN, L
    ERLICH, HA
    HUMAN IMMUNOLOGY, 1988, 23 (02) : 81 - 81
  • [23] HLA CLASS-II MOLECULES AND AUTOIMMUNE HEPATITIS SUSCEPTIBILITY IN JAPANESE PATIENTS
    SEKI, T
    OTA, M
    FURUTA, S
    FUKUSHIMA, H
    KONDO, T
    HINO, K
    MIZUKI, N
    ANDO, A
    TSUJI, K
    INOKO, H
    KIYOSAWA, K
    GASTROENTEROLOGY, 1992, 103 (03) : 1041 - 1047
  • [24] Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice
    Yang, H
    Goluszko, E
    David, C
    Okita, DK
    Conti-Fine, B
    Chan, TS
    Poussin, MA
    Christadoss, P
    JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (08): : 1111 - 1120
  • [25] Association of HLA Class II Alleles with Disease Severity and Treatment Response in Iranian Patients with Myasthenia Gravis
    Sinaei, Farnaz
    Fatehi, Farzad
    Gharan, Shahram Oveis
    Ehsan, Soroush
    Kamali, Koorosh
    Amirzargar, Aliakbar
    Mahmoudi, Mahdi
    Vaghefifar, Alaleh
    Nafissi, Shahriar
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (05) : 827 - 829
  • [26] Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice
    Abraham, RS
    David, CS
    CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) : 122 - 129
  • [27] A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice
    Pennesi, G
    Mattapallil, M
    Sun, SH
    Avichezer, D
    Silver, PB
    Karabekian, Z
    David, CS
    Hargrave, PA
    McDowell, JH
    Smith, WC
    Wiggert, B
    Donoso, LA
    Chan, CC
    Caspi, RR
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (08): : 1171 - 1180
  • [28] Immune responses to snRNP protein SmD in HLA class II transgenic mice
    Jiang, C
    Deshmukh, US
    Gaskin, F
    David, CS
    Fu, SM
    Shewade, Y
    FASEB JOURNAL, 2004, 18 (05): : A843 - A843
  • [29] Use of peptide:HLA class II complexes to study specific T cells in autoimmune myasthenia gravis
    Kishore, U
    Zhang, W
    Corlett, L
    Waters, P
    Glaichenhaus, N
    Willcox, N
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 339 - 342
  • [30] Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules
    Pajot, A
    Pancré, W
    Fazilleau, N
    Michel, ML
    Angyalosi, G
    Ojcius, DM
    Auriault, C
    Lemonnier, FA
    Lone, YC
    INTERNATIONAL IMMUNOLOGY, 2004, 16 (09) : 1275 - 1282
12345